Similar Superantigen Gene Profiles and Superantigen Activity in Norwegian Isolates of Invasive and Non-Invasive Group A Streptococci

Scandinavian Journal of Immunology

Volumn 74, Issue 5, 2011, Pages 423-429

  Michaelsen, T E ^a,b   Andreasson, I K G ^a   Langerud, B K ^a   Caugant, D A ^a,b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERANTIGEN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; NECROTIZING FASCIITIS; NONHUMAN; NORWAY; PRIORITY JOURNAL; STREPTOCOCCAL PHARYNGITIS; STREPTOCOCCUS GROUP A; T LYMPHOCYTE; TOXIC SHOCK SYNDROME;

ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CELLS, CULTURED; DISEASE PROGRESSION; FASCIITIS, NECROTIZING; GENE EXPRESSION PROFILING; GENES, BACTERIAL; HUMANS; LYMPHOCYTE ACTIVATION; NORWAY; PHARYNGITIS; POLYMORPHISM, GENETIC; SEROTYPING; SHOCK, SEPTIC; STAPHYLOCOCCAL SKIN INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; T-LYMPHOCYTES; VIRULENCE;

EID: 80053558317     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02594.x     Document Type: Article

References (31)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000;13:470-511.
2. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 1993;269:384-9.
3. Stevens DL. Streptococcal toxic shock syndrome. Clin Microbiol Infect 2002;8:133-6.
4. Miller AT, Saadai P, Greenstein A, Divino CM. Postprocedural necrotizing fasciitis: a 10-year retrospective review. Am Surg 2008;74:405-9.
5. Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect Dis 2003;3:191-200.
6. Wahl RU, Lutticken R, Stanzel S, van der Linden M, Reinert RR. Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system. Clin Microbiol Infect 2007;13:1173-8.
7. Schmitz FJ, Beyer A, Charpentier E et al. Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 2003;188:1578-86.
8. Miyoshi-Akiyama T, Zhao J, Kikuchi K et al. Quantitative and qualitative comparison of virulence traits, including murine lethality, among different M types of group A streptococci. J Infect Dis 2003;187:1876-87.
9. O'Brien KL, Beall B, Barrett NL et al. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002;35:268-76.
10. Sharkawy A, Low DE, Saginur R et al. Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 2002;34:454-60.
11. Veasy LG, Tani LY, Daly JA et al. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 2004;113:e168-72.
12. Creti R, Imperi M, Baldassarri L et al. emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11years? J Clin Microbiol 2007;45:2249-56.
13. Meisal R, Hoiby EA, Aaberge IS, Caugant DA. Sequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003. J Clin Microbiol 2008;46:2102-5.
14. Vlaminckx B, van PW, Schouls L et al. Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996. Eur J Clin Microbiol Infect Dis 2004;23:434-44.
15. Norrby-Teglund A, Thulin P, Gan BS et al. Evidence for superantigen involvement in severe group a streptococcal tissue infections. J Infect Dis 2001;184:853-60.
16. Sriskandan S, Faulkner L, Hopkins P. Streptococcus pyogenes: insight into the function of the streptococcal superantigens. Int J Biochem Cell Biol 2007;39:12-9.
17. Kotb M, Norrby-Teglund A, McGeer A et al. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002;8:1398-404.
18. Nooh MM, El-Gengehi N, Kansal R, David CS, Kotb M. HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis. J Immunol 2007;178:3076-83.
19. Maripuu L, Eriksson A, Norgren M. Superantigen gene profile diversity among clinical group A streptococcal isolates. FEMS Immunol Med Microbiol 2008;54:236-44.
20. Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol 2003;133:299-306.
21. Vikerfors A, Haggar A, Darenberg J et al. Severe group A streptococcal infections in Uppsala County, Sweden: clinical and molecular characterization of a case cluster from 2006 to 2007. Scand J Infect Dis 2009;41:823-30.
22. Meisal R, Andreasson IK, Hoiby EA, Aaberge IS, Michaelsen TE, Caugant DA. Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles. J Clin Microbiol 2010;48:842-51.
23. Broudy TB, Pancholi V, Fischetti VA. Induction of lysogenic bacteriophage and phage-associated toxin from group a streptococci during coculture with human pharyngeal cells. Infect Immun 2001;69:1440-3.
24. Naess LM, Oftung F, Aase A, Wetzler LM, Sandin R, Michaelsen TE. Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine. Infect Immun 1998;66:959-65.
25. Pandiripally V, Gregory E, Cue D. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1. Infect Immunol 2002;70:6206-14.
26. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989;56:27-35.
27. Leonard BA, Lee PK, Jenkins MK, Schlievert PM. Cell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity. Infect Immun 1991;59:1210-4.
28. Murakami J, Kawabata S, Terao Y et al. Distribution of emm genotypes and superantigen genes of Streptococcus pyogenes isolated in Japan, 1994-9. Epidemiol Infect 2002;128:397-404.
29. Ma Y, Yang Y, Huang M et al. Characterization of emm types and superantigens of Streptococcus pyogenes isolates from children during two sampling periods. Epidemiol Infect 2009;137:1414-9.
30. Commons R, Rogers S, Gooding T et al. Superantigen genes in group A streptococcal isolates and their relationship with emm types. J Med Microbiol 2008;57:1238-46.
31. Norrby-Teglund A, Nepom GT, Kotb M. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles. Eur J Immunol 2002;32:2570-7.